Whether CDC42 activity is compromised also in CMT4D, due to NDRG1 inactivation, is presently unknown, and might thus provide a starting-point for further studies into the molecular pathogenesis of CMT4D. This evidence concerns the gene NDRG1 and Charcot-Marie-Tooth disease type 4D.